Elevance Health (ELV) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
6 Jan, 2026Opening remarks and agenda
Chair called the meeting to order, outlined voting and Q&A procedures, and introduced board members and auditors.
Agenda and rules of conduct were posted online, with voting and Q&A to follow formal procedures.
Board and executive committee updates
Liz Tallett was recognized for her leadership as independent Chair since 2018, with Rami Peru welcomed as the new independent Chair.
Shareholder proposals
A shareholder proposal requested a report on the effectiveness of diversity, equity, and inclusion efforts, citing industry benchmarks and urging greater transparency.
The Board recommended against the proposal.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Elevance Health
- 2025 saw double-digit revenue growth, robust ESG progress, and strong board and pay governance.ELV
Proxy filing27 Mar 2026 - Virtual annual meeting to vote on directors, pay, auditors, and a political contributions ESG proposal.ELVProxy filing27 Mar 2026
- 2026 guidance is cautious, but margin recovery and 12%+ EPS growth are targeted for 2027.ELVQ4 20253 Feb 2026
- Stable trends, disciplined growth, and strategic expansion in care and specialty services.ELVGoldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026
- Q2 adjusted EPS up 12% to $10.12; Carelon growth and divestitures offset Medicaid declines.ELVQ2 20243 Feb 2026
- Q3 2024 revenue up 5.3% to $44.7B; net income down 22.5% amid Medicaid cost pressures.ELVQ3 202419 Jan 2026
- AI investments, M&A, and Carelon expansion drive growth amid Medicaid and MA margin pressures.ELVUBS Global Healthcare Conference 202414 Jan 2026
- 2024 revenue up 3% to $175.2B; 2025 outlook sees higher EPS and strong capital returns.ELVQ4 20249 Jan 2026
- Q1 2025 revenue up 15.4%, adjusted EPS up 10.5%, net income down 2.9%, guidance reaffirmed.ELVQ1 202521 Dec 2025